ForSight Labs: ForSight Vision5 Raises $15m in Funding Round led by H.I.G. BioVentures

ForSight VISION5 is pleased to announce it has recently closed its Series C round of funding and has also completed enrollment in its Phase 2 Clinical Study for the HeliosTM ocular insert, its lead product candidate. ForSight VISION5 is developing non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye […]The post ForSight Vision5 Raises $15m in Funding Round led by H.I.G. BioVentures appeared first on Deal Feed International.